Congress isn’t acting to curb drug prices, so states are stepping up. Here’s how
With little action in Congress, states from California to Vermont are experimenting with ways to try to curb drug prices or shine a light on rising costs.
President Trump has complained that drug makers are getting away with murder — and he may be right.
Despite vociferous complaints from consumers that drug prices are too high, Congress has failed to act. And with few exceptions, the pharmaceutical industry has successfully delayed or thwarted state bills that would force drug makers to explain or justify price hikes.
But that may be starting to change. Last week, of the pharma industry, already has a similar policy in place. recently began requiring drug makers to disclose pricing data about diabetes medicines. And has a new law that penalizes generic companies for price gouging.
